OBJECTIVE: : Determining the brain substrates underlying the motivation to abuse addictive drugs is critical for understanding and treating addictive disorders. Laboratory neuroimaging studies have demonstrated differential activation of limbic and motivational circuitry (eg, amygdala, hippocampus, ventral striatum, insula, and orbitofrontal cortex) triggered by cocaine, heroin, nicotine, and alcohol cues. The literature on neural responses to marijuana cues is sparse. Thus, the goals of this study were to characterize the brain's response to marijuana cues, a major motivator underlying drug use and relapse, and determine whether these responses are linked to self-reported craving in a clinically relevant population of treatment-seeking marijuana-dependent subjects. METHODS: : Marijuana craving was assessed in 12 marijuana-dependent subjects using the Marijuana Craving Questionnaire-Short Form. Subsequently, blood oxygen level dependent functional magnetic resonance imaging data were acquired during exposure to alternating 20-second blocks of marijuana-related versus matched nondrug visual cues. RESULTS: : Brain activation during marijuana cue exposure was significantly greater in the bilateral amygdala and the hippocampus. Significant positive correlations between craving scores and brain activation were found in the ventral striatum and the medial and lateral orbitofrontal cortex (P < 0.0001). CONCLUSIONS: : This study presents direct evidence for a link between reward-relevant brain responses to marijuana cues and craving and extends the current literature on marijuana cue reactivity. Furthermore, the correlative relationship between craving and brain activity in reward-related regions was observed in a clinically relevant sample (treatment-seeking marijuana-dependent subjects). Results are consistent with prior findings in cocaine, heroin, nicotine, and alcohol cue studies, indicating that the brain substrates of cue-triggered drug motivation are shared across abused substances.
RCT Entities:
OBJECTIVE: : Determining the brain substrates underlying the motivation to abuse addictive drugs is critical for understanding and treating addictive disorders. Laboratory neuroimaging studies have demonstrated differential activation of limbic and motivational circuitry (eg, amygdala, hippocampus, ventral striatum, insula, and orbitofrontal cortex) triggered by cocaine, heroin, nicotine, and alcohol cues. The literature on neural responses to marijuana cues is sparse. Thus, the goals of this study were to characterize the brain's response to marijuana cues, a major motivator underlying drug use and relapse, and determine whether these responses are linked to self-reported craving in a clinically relevant population of treatment-seeking marijuana-dependent subjects. METHODS: : Marijuana craving was assessed in 12 marijuana-dependent subjects using the Marijuana Craving Questionnaire-Short Form. Subsequently, blood oxygen level dependent functional magnetic resonance imaging data were acquired during exposure to alternating 20-second blocks of marijuana-related versus matched nondrug visual cues. RESULTS: : Brain activation during marijuana cue exposure was significantly greater in the bilateral amygdala and the hippocampus. Significant positive correlations between craving scores and brain activation were found in the ventral striatum and the medial and lateral orbitofrontal cortex (P < 0.0001). CONCLUSIONS: : This study presents direct evidence for a link between reward-relevant brain responses to marijuana cues and craving and extends the current literature on marijuana cue reactivity. Furthermore, the correlative relationship between craving and brain activity in reward-related regions was observed in a clinically relevant sample (treatment-seeking marijuana-dependent subjects). Results are consistent with prior findings in cocaine, heroin, nicotine, and alcohol cue studies, indicating that the brain substrates of cue-triggered drug motivation are shared across abused substances.
Authors: Teresa R Franklin; Ze Wang; Jiongjiong Wang; Nathan Sciortino; Derek Harper; Yin Li; Ron Ehrman; Kyle Kampman; Charles P O'Brien; John A Detre; Anna Rose Childress Journal: Neuropsychopharmacology Date: 2007-03-21 Impact factor: 7.853
Authors: David W Oslin; Mark Cary; Valarie Slaymaker; Carol Colleran; Frederic C Blow Journal: Drug Alcohol Depend Date: 2009-05-14 Impact factor: 4.492
Authors: Stephen J Heishman; Rebecca J Evans; Edward G Singleton; Kenneth H Levin; Marc L Copersino; David A Gorelick Journal: Drug Alcohol Depend Date: 2009-02-13 Impact factor: 4.492
Authors: Patrick S Bordnick; Hilary L Copp; Amy Traylor; Ken M Graap; Brian L Carter; Alicia Walton; Mirtha Ferrer Journal: J Psychoactive Drugs Date: 2009-06
Authors: Teresa R Franklin; Falk W Lohoff; Ze Wang; Nathan Sciortino; Derek Harper; Yin Li; Will Jens; Jeffrey Cruz; Kyle Kampman; Ron Ehrman; Wade Berrettini; John A Detre; Charles P O'Brien; Anna Rose Childress Journal: Neuropsychopharmacology Date: 2008-08-13 Impact factor: 7.853
Authors: Francesca M Filbey; Joseph P Schacht; Ursula S Myers; Robert S Chavez; Kent E Hutchison Journal: Proc Natl Acad Sci U S A Date: 2009-07-27 Impact factor: 11.205
Authors: Deborah S Hasin; Katherine M Keyes; Donald Alderson; Shuang Wang; Efrat Aharonovich; Bridget F Grant Journal: J Clin Psychiatry Date: 2008-09-09 Impact factor: 4.384
Authors: Daniel D Langleben; Kosha Ruparel; Igor Elman; Samantha Busch-Winokur; Ramapriyan Pratiwadi; James Loughead; Charles P O'Brien; Anna R Childress Journal: Am J Psychiatry Date: 2007-12-03 Impact factor: 18.112
Authors: Anna Rose Childress; Ronald N Ehrman; Ze Wang; Yin Li; Nathan Sciortino; Jonathan Hakun; William Jens; Jesse Suh; John Listerud; Kathleen Marquez; Teresa Franklin; Daniel Langleben; John Detre; Charles P O'Brien Journal: PLoS One Date: 2008-01-30 Impact factor: 3.240
Authors: Jason M Wiebelhaus; Travis W Grim; Robert A Owens; Matthew F Lazenka; Laura J Sim-Selley; Rehab A Abdullah; Micah J Niphakis; Robert E Vann; Benjamin F Cravatt; Jenny L Wiley; S Stevens Negus; Aron H Lichtman Journal: J Pharmacol Exp Ther Date: 2014-11-14 Impact factor: 4.030
Authors: Hollis C Karoly; Joseph P Schacht; Joanna Jacobus; Lindsay R Meredith; Charles T Taylor; Susan F Tapert; Kevin M Gray; Lindsay M Squeglia Journal: Drug Alcohol Depend Date: 2019-05-14 Impact factor: 4.492
Authors: Sarah W Yip; Elise E DeVito; Hedy Kober; Patrick D Worhunsky; Kathleen M Carroll; Marc N Potenza Journal: Drug Alcohol Depend Date: 2014-04-13 Impact factor: 4.492
Authors: Jenessa S Price; Tim McQueeny; Skyler Shollenbarger; Erin L Browning; Jon Wieser; Krista M Lisdahl Journal: Psychopharmacology (Berl) Date: 2015-04-30 Impact factor: 4.530
Authors: B Froeliger; P A McConnell; N Stankeviciute; E A McClure; P W Kalivas; K M Gray Journal: Drug Alcohol Depend Date: 2015-09-26 Impact factor: 4.492